PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.00%
OCF growth of 0.00% while ECL.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
0.00%
FCF growth of 0.00% while ECL.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-68.82%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
2.04%
Positive 5Y CAGR while ECL.AX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
23.51%
3Y revenue/share CAGR under 50% of ECL.AX's 60.11%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-134.17%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-118.13%
Negative 5Y OCF/share CAGR while ECL.AX is at 48.44%. Joel Greenblatt would question the firm’s operational model or cost structure.
-124.87%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
177.00%
Below 50% of ECL.AX's 431.85%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
133.44%
5Y net income/share CAGR above 1.5x ECL.AX's 5.22%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
100.00%
3Y net income/share CAGR above 1.5x ECL.AX's 49.91%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
9681.11%
Positive 5Y equity/share CAGR while ECL.AX is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
260.24%
3Y equity/share CAGR above 1.5x ECL.AX's 6.82%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
29.78%
AR growth of 29.78% while ECL.AX is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.